Login
← Go Back
Supriya Lifescience
SUPRIYA · Pharma > Pharmaceuticals & Drugs · Chairman: Satish Waman Wagh · MD: Satish Waman Wagh · Listing date: Dec. 29, 2021
Stock Price vs Company Growth
1d
3.5%
1w
2.4%
1m
7.2%
3m
12.9%
6m
5.6%
1y
4.4%
all
9.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 685 3.5%
643
818
Company Overview
Sales
735 Cr
Growth: 12.5%
Profit after Tax
185 Cr
Growth: 1.6%
Small Cap
5,512 Cr
P/E: 29.7x
Industry P/E: 29.7x
Fundamentals
Sales (Cr) ₹ 735
Growth 12.5%
EBITDA 35.9%
P/S 7.5x
Dividend 0.1%
P/E 29.7x
Book Value ₹ 2
PEG Ratio 2.4x
ROE 999.0%
P/B N/A
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. The company has niche product offerings of various APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic.
Belongs to (11 Indices) view more
Investors (5)
jyotsana
rajeev4
shivani....
Followers (1)
varsha96